Vicki L Sato
Director at Vir Biotechnology, Inc. (VIR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 4SEC | VIRVir Biotechnology, Inc. | Sell Plan | 22,0001,078,391 held (−2%) | $10.05 | $221K | +16.4% |
| Apr 2SEC | VIRVir Biotechnology, Inc. | Sell Plan | 22,0001,100,391 held (−2%) | $9.07 | $200K | +29.0% |
| Mar 3SEC | VIRVir Biotechnology, Inc. | Sell Plan | 21,8001,122,591 held (−2%) | $9.50 | $207K | +23.2% |
| Mar 3SEC | VIRVir Biotechnology, Inc. | Sell Plan | 2001,122,391 held (−0%) | $9.98 | $2K | +17.2% |
| Feb 26SEC | VIRVir Biotechnology, Inc. | Sell Plan | 42,1771,144,591 held (−4%) | $9.75 | $411K | +20.0% |
| Feb 26SEC | VIRVir Biotechnology, Inc. | Sell Plan | 2001,144,391 held (−0%) | $10.26 | $2K | +14.0% |
| Feb 3SEC | VIRVir Biotechnology, Inc. | Sell Plan | 22,0001,144,391 held (−2%) | $7.71 | $170K | +51.8% |
| Jan 5SEC | VIRVir Biotechnology, Inc. | Sell Plan | 22,0001,166,391 held (−2%) | $5.93 | $130K | +97.3% |
| Dec 2SEC | VIRVir Biotechnology, Inc. | Sell Plan | 22,0001,188,391 held (−2%) | $6.00 | $132K | +95.0% |
| Nov 4SEC | VIRVir Biotechnology, Inc. | Sell Plan | 22,0001,210,391 held (−2%) | $5.64 | $124K | +107.4% |
| Oct 2SEC | VIRVir Biotechnology, Inc. | Sell Plan | 22,0001,232,391 held (−2%) | $5.84 | $128K | +100.3% |
- Sell
Director Vicki L Sato sold $221K of VIR at $10.05 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Vicki L Sato sold $200K of VIR at $9.07 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Vicki L Sato sold $207K of VIR at $9.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Vicki L Sato sold $2K of VIR at $9.98 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Vicki L Sato sold $411K of VIR at $9.75 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Vicki L Sato sold $2K of VIR at $10.26 — pre-scheduled 10b5-1 plan sale.